Arrowhead Pharmaceuticals Inc (ARWR)
- Exchange
- NASDAQ
- Symbol
- ARWR
- Sector
- Trade & Services
- Industry
- Services-commercial Physical & Biological Research
- Description
- Arrowhead Pharmaceuticals, Inc. develops drugs for the treatment of intractable diseases in the United States. The company is headquartered in Pasadena, California.
- Country
- USA
Stock price
At close: November 6, 2024
-
Open21.30
-
High21.79
-
Low21.07
-
Close21.34
-
Volume1,888,950
Financial ratios
Dec 31, 2023
Activity ratios
Liquidity ratios
Solvency ratios
Profitability ratios
Inventory turnover
—
Receivables turnover
—
Payables turnover
23.34
Working capital turnover
0.95
Days of inventory on hand (DOH)
—
Days of sales outstanding (DSO)
—
Number of days of payables
15.64
Fixed asset turnover
0.50
Total asset turnover
0.27
Current ratio
3.73
Quick ratio
3.46
Cash ratio
3.46
Cash conversion cycle
-15.64
Debt-to-assets ratio
0.00
Debt-to-capital ratio
0.00
Debt-to-equity ratio
0.00
Financial leverage ratio
3.90
Interest coverage
-13.27
Gross profit margin
34.21%
Operating profit margin
-180.08%
Pretax margin
-178.85%
Net profit margin
-178.52%
Operating return on assets (Operating ROA)
-47.81%
Return on assets (ROA)
-47.39%
Return on total capital
-172.38%
Return on equity (ROE)
-185.04%